Jeanelle Kam, MD, MBA, CPI

Dr. Kam is a trained OB/GYN with more than a decade of CRU early drug development experience across multiple indications. As a Certified Physician Investigator (CPI) and Medical Director at the Phase I Dallas CRU, Dr. Kam conducted over 200 trials in BE, DDI, FE, FIH, Japanese Bridging and TQT studies. In 2022, she joined the CPS Medical Scientific Team as a Phase I Medical Monitor and currently is one of the Senior Medical Director at Fortrea. Her expertise in Women’s Reproductive Health includes serving as PI on OC-DDI studies, consultation of endometriosis, lactation and post-menopausal studies. She was the lead author for Fortrea’ s birth control guidance, “Evidence-Based Guidance for Contraceptive Use in Phase I and Clinical Pharmacology Trials Including Women of Child-Bearing Potential” and presentation of the guidance at the 2015 Annual Meeting for ACCP poster session.